Charles Grob

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Charles Grob is a professor of Psychiatry & Biobehavioral Sciences and Pediatrics and Director of the Division of Child and Adolescent Psychiatry at Harbor-UCLA Medical Center.[1] He received his two BS degrees from Oberlin College and Columbia University before receiving an MD from the State University of New York, Downstate Medical Center. Grob’s research interests include anxiety and mood disorders and also self-medication and substance abuse. The FDA approved one of his Phase 1 studies to study the psychological and physiological effects of MDMA and the hallucinogen Ayahuasca.[2][3][4][5]

Grob is also the editor of the book Hallucinogens: A reader, originally published in 2002 this book is a collection of psychedelic texts covering a wide range of topics like shamanism, society and psilocybin research. It contains excerpts from figureheads of the psychedelic movement like Terrence McKenna, Albert Hoffman and Ralph Metzner.[6][7]

Research projects[edit]

1) The Hoasca Project- Hoasca is a plant-based botanically developed beverage that is used as a component of ritualistic practices in Brazil by the members of UDV, a syncretic religious movement in Brazil. It is the most comprehensive and in-depth study done on the relationship between Ayahuasca and mental health.[8][9][10]

2) Psilocybin- Charles Grob conducted a study that observed the effect on psilocybin when used by patients with advanced cancer and existential anxiety. From 2004 to 2008 the research group at Harbor- UCLA Medical Center conducted a double-blind, placebo-controlled investigation examining the safety and efficacy of psilocybin as a treatment for advanced-cancer anxiety. A total of twelve subjects were studied, all of whom tolerated the experimental treatment without adverse effects.[11][12]

References[edit]

  1. ^ "Charles S. Grob, M.D. – Harbor-UCLA Psychiatry". www.harboruclapsych.com. Retrieved 2018-07-22.
  2. ^ Walsh RedGrob CSed Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics. Albany State University of New York2005;
  3. ^ Grob CS The use of psilocybin in patients with advanced cancer and existential anxiety. Winkelman MJRoberts TBeds.Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatment. Westport, CT Praeger2007;205- 216
  4. ^ "Charles Grob, MD - LA BioMed".
  5. ^ "Charles S. Grob, M.D. – psychedelic researcher – Psychedelic Salon Podcasts".
  6. ^ PsypressUK (9 March 2010). "Hallucinogens A Reader by Charles S. Grob (Ed)".
  7. ^ Grob CSed Hallucinogens: A Reader. New York, NY Tarcher/Putnam2002;
  8. ^ "The Hoasca Project". 28 March 2013.
  9. ^ "MAPS - Volume 5 Number 4 Summer 1995 - The Hoasca Project: Current Status".
  10. ^ MilagrosL7 (12 March 2011). "Dr. Charles Grob- Ayahuasca & Hallucinogens- Clinical studies- Past Present and Future" – via YouTube.
  11. ^ Grob CS The use of psilocybin in patients with advanced cancer and existential anxiety. Winkelman MJRoberts TBeds.Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatment. Westport, CT Praeger2007;205- 216. http://www.csam-asam.org/sites/default/files/pdf/misc/Grob_Article.pdf
  12. ^ MAPS (24 July 2013). "Psilocybin at the End of Life - Charles Grob" – via YouTube.